WIA-SPACE-009 protects astronauts and spacecraft from space radiation across every phase of a mission. Its stated operating contexts are Low Earth Orbit (LEO), lunar missions and surface operations, Mars expeditions and deep space exploration, extravehicular activity (EVA), and emergency radiation events. The scope runs from the physics of the sources through risk assessment, passive and active shielding, monitoring, operational procedures, medical countermeasures, and mission planning. The normative references are ICRP publications, NASA STD-3001, ISO 15390 for galactic cosmic rays, and NCRP reports on space radiation.
The standard is published in four phases, and this chapter follows the same split:
The numbers in the standard, such as dose limits, shielding thicknesses, and alert levels, are tied to the data structures that carry them. The sections below keep that link visible.
On the ground, the atmosphere and the geomagnetic field absorb or deflect most of the particles that reach a spacecraft. Beyond them, crews meet energetic protons, helium nuclei, and a small fraction of heavy ions (HZE particles) that penetrate structures and tissue. Dose cannot be avoided, only budgeted. The standard therefore frames protection as the ALARA principle, keeping exposure as low as reasonably achievable through three levers:
Three quantities recur throughout the standard. Absorbed dose is expressed in gray (Gy). Equivalent dose is expressed in sievert (Sv) and weights the absorbed dose by how damaging each particle type is. Effective dose, also in Sv, further weights by tissue sensitivity. The Phase 1 data format builds these distinctions into the dose record. Equivalent dose uses the ICRP 103 radiation weighting factors (w_R), and effective dose uses the ICRP 103 tissue weighting factors (w_T). Because biological damage depends on how densely a particle deposits energy, the standard also requires the linear energy transfer (LET) spectrum to be measured. It is needed to determine the quality factor.
Each mission phase puts a different source in front of the crew. In LEO, the trapped belts and the South Atlantic Anomaly dominate. In cislunar and interplanetary space, galactic cosmic rays and solar particle events dominate. The sections that follow keep these cases separate, because the protective action differs for each.
The standard groups sources by physical mechanism. In the source record it adds secondary radiation, meaning neutrons and spallation products produced inside shielding, and gamma-ray bursts as a further category. The three principal environments are compared below.
| Source | Composition and energy | Time behaviour | Protection character |
|---|---|---|---|
| Galactic cosmic rays (GCR) | ~85% protons, ~14% helium, ~1% HZE; hundreds of MeV to hundreds of GeV | Continuous; modulated by the solar cycle (30-50% variation) | High risk beyond 6 months; complete shielding would need meters of material |
| Solar particle events (SPE) | >90% protons; tens to hundreds of MeV | Hours to days; correlated with the solar cycle; warning of 10 minutes to several hours | Very high risk during an event, with acute radiation syndrome possible |
| Trapped radiation | Inner belt: high-energy protons. Outer belt: electrons (0.1-10 MeV) | Inner belt very stable; outer belt highly variable | Mainly an issue for LEO and belt transits |
The contrast between GCR and SPE drives most of the design. GCR is a chronic background that shielding can only reduce, so it is handled through the mission dose budget. An SPE is an acute episode with a short warning, so it is handled by procedure and by a shelter. The belt geometry matters as well. The inner belt lies at roughly 1,000-6,000 km and the outer belt at roughly 13,000-60,000 km. The South Atlantic Anomaly, near 30°S, 60°W, contributes 70-80% of an ISS astronaut's dose, with 5-6 transits a day on the ISS orbit.
The Phase 1 source-record envelope captures this physical structure. It carries a source identifier, an energy spectrum (LET in keV/μm, a particle-type breakdown, and a flux-energy distribution), a temporal envelope, and a spatial envelope. The temporal envelope is steady-state for GCR, event-driven for SPE with onset time, peak time, and duration, and orbital for trapped radiation. The spatial envelope covers heliocentric distance, geomagnetic cutoff rigidity, and shielding-thickness context. A forecaster's SPE message and a belt-model output can therefore be stored in one structure and still keep their different time behaviour. The standard names the supporting models: HZETRN 2015 for transport, and AE-9/AP-9 for the trapped belts.
The risk metric is the Risk of Exposure-Induced Death (REID). The career limits are set at a 3% REID, so they depend on sex and age at exposure:
| Age at exposure | Female career limit | Male career limit |
|---|---|---|
| 25 | 600 mSv | 800 mSv |
| 35 | 900 mSv | 1,000 mSv |
| 45 | 1,100 mSv | 1,200 mSv |
The standard adds short-term and organ-specific limits. The short-term limits are 250 mSv over 30 days and 500 mSv per year. The eye lens has a career limit of 2,000 mSv, set to prevent cataracts. The skin has a 30-day limit of 6,000 mSv, set to prevent acute skin damage. These limits address different endpoints. Career limits address late cancer risk, while the short-term and skin limits address acute harm. A crew member can be well inside a career limit and still approach a 30-day limit during an SPE.
The dose-record envelope is how these limits become checkable. Each record carries:
The record carries uncertainty explicitly, so a limit comparison is made on a value with a stated error rather than on a bare number. On submission, the API deduplicates records by a content-addressed SHA-256 hash and computes rolling 30-day and annual totals against the risk criterion. It emits a dose-threshold alert as a rolling total approaches 50%, 75%, and 90% of the applicable limit. Against the 30-day limit of 250 mSv, those thresholds fall at 125, 187.5, and 225 mSv. Crew dose data is encrypted at rest, with the key bound to the operator's medical-officer credential.
The health effects do not end at landing. Within 7 days the standard calls for a physical examination, blood tests including a complete blood count and biomarkers, chromosome aberration analysis, cognitive testing, and an ophthalmological exam. All dosimeter read-outs are collected and the career dose is updated. Annual follow-up adds enhanced cancer screening, cardiovascular evaluation, cognitive testing, and cataract screening. A lifetime database keeps exposure history for correlation and epidemiological study. The research priorities are open questions the limits cannot yet settle. They include low-dose and low-dose-rate effects, HZE biological mechanisms, individual radiosensitivity, central-nervous-system effects, and combined stressors such as radiation with microgravity and isolation.
Shielding requirements are given in areal density (g/cm²), the mass per unit area presented to the radiation. The habitat minimum is 10 g/cm² aluminum equivalent. Sleeping quarters should have 20 g/cm². A storm shelter should reach 40 g/cm² of polyethylene or water equivalent. The shelter design section gives an effective thickness range of 20-40 g/cm².
The material priority is: hydrogen-rich materials first, multi-layer structures second, and low-Z materials to limit secondary radiation. Light nuclei fragment heavy ions without producing as many secondary particles as dense, high-Z metals do. That is why plain aluminum is only a structural baseline.
| Material | Density (g/cm³) | Hydrogen content | Application |
|---|---|---|---|
| Polyethylene | 0.92 | 14% | Dedicated shielding layers |
| Water | 1.0 | 11% | Multi-purpose (life support + shielding) |
| Aluminum | 2.7 | 0% | Structural (baseline) |
| Boron composite | 1.8-2.5 | Varies | Neutron capture |
Water earns a place in the list because the same mass serves life support and shielding. Boron composite appears for a narrower reason: it captures the neutrons that other layers generate.
The storm shelter is specified as a system rather than a thick wall. It must hold all crew members and be self-sufficient for at least 72 hours. It sits in a central area with maximum shielding and must be reachable within 15 minutes from any location. Its life support list is oxygen supply, CO₂ removal, temperature control, food and water, waste management, and communications. The access time ties the layout to the response procedure in 8.7.
The weakest point is the EVA suit. The current EMU provides about 0.1-0.2 g/cm². The enhancement targets are 0.5 g/cm² over the torso to protect critical organs, a polycarbonate helmet with hydrogen gel, and flexible joints woven from polyethylene fiber. Since suit shielding is so thin, EVA relies on procedure and monitoring far more than habitat time does. Mission planning also contributes to protection. The standard calls for the fastest trajectory through the thinnest regions of the Van Allen belts and for Earth-shadow use where possible.
Monitoring is layered by purpose. Personal passive dosimeters give the official record. A thermoluminescent dosimeter (TLD) is required, at least two per crew member, with an optically stimulated luminescence (OSL) dosimeter as a backup. Read-out is weekly at minimum and again after the mission. Active dosimeters give the live view. They display dose and dose rate, alarm at 2x background, log at a minimum 1-hour resolution, and transmit wirelessly to the health monitoring system. Required measurements are absorbed dose (Gy), dose equivalent (Sv), dose rate (mSv/day), and the LET spectrum.
Area monitoring complements personal devices. Fixed monitors in every habitable module measure continuous dose rate, alert automatically when a threshold is exceeded, and archive data for the mission. Environmental monitors watch the external field: particle flux, energy spectrum, and real-time SPE detection. The timing requirements are:
The Phase 2 API exposes this path. The endpoints below are those the standard lists:
POST /space-radiation/v1/missions # register mission
GET /space-radiation/v1/missions/{id} # fetch mission
POST /space-radiation/v1/dose-records # submit dose
GET /space-radiation/v1/dose-records/{id} # fetch dose
GET /space-radiation/v1/dose-records/crew/{cid} # crew dose history
POST /space-radiation/v1/dosimeters # register dosimeter
GET /space-radiation/v1/dosimeters/{id}/state # dosimeter state
POST /space-radiation/v1/spe-alerts # SPE alert ingest
WS /space-radiation/v1/state/stream # real-time stream
GET /space-radiation/v1/audit/{id} # audit trailSeveral behaviours address the radiation problem directly. Mission registration computes a mission radiation budget and requires it to carry an explicit confidence percentile, an explicit worst-case SPE assumption, and an explicit GCR solar-modulation assumption, so every consumer of the budget reads the same assumptions. A dosimeter whose calibration is due moves automatically to the out-of-calibration state with a warning event, and position changes are recorded as immutable events. State retrieval returns the latest dose rate, the cumulative dose since deployment, and, for active units, battery, buffer fill, and last-contact time. The SPE alert endpoint accepts messages from upstream forecasters such as NOAA SWPC and ESA SEPEM. It validates each one against the operator's alert policy using the NOAA S-scale (minor, moderate, major, extreme) and merges duplicates from several sources into one normalised alert. That alert is pushed to the SPE response protocol. Crew dose endpoints require a medical-officer credential in addition to the privacy scope.
Operational protocol begins before launch. Planning weighs the solar-cycle position, the SPE probability, and the predicted GCR flux when choosing a launch window. It also trades transit time against surface stay time inside a dose budget allocation.
EVA is gated by explicit conditions. Before an EVA, the team reviews the solar activity forecast for the previous 48 hours and assesses the current environment. A go decision requires all of the following:
During the EVA, personal dosimeters and ground monitoring run continuously and time limits are enforced. The abort criteria are an SPE warning, a dose rate above 5x background, or a cumulative dose approaching the daily limit. Afterwards the dosimeter is read, crew health is assessed, and the cumulative dose is updated. The EVA limits are 8 hours for a single EVA and 16 hours per week, with the mission total set by the dose budget.
SPE response uses four alert levels that escalate from monitoring to evacuation:
| Level | Condition | Action |
|---|---|---|
| Green | Normal | Continue operations |
| Yellow | M-class flare or dose rate 2x background | Increase monitoring, review EVA |
| Orange | X-class flare or SPE predicted | Abort EVA, prepare shelter |
| Red | SPE in progress, dose rate >10x | Immediate shelter evacuation |
The shelter procedure has seven steps: alert reception, ceasing non-essential activities, shelter entry (target under 15 minutes), hatch closure and verification, continuous monitoring with internal and external dosimeters, ground communication, and a stay that lasts until the dose rate returns below 2x background. While sheltering, the crew minimises movement to conserve energy, monitors health, keeps communications open, and receives psychological support. The 15-minute entry target is the operational counterpart of the 15-minute access requirement on the shelter itself. The normalised alert from the Phase 2 ingest endpoint is the trigger that connects forecasting to this procedure.
The standard separates medical countermeasures by when they are given. Radioprotectors are given before exposure to prevent or reduce cellular damage. The candidates are amifostine (WR-2721), which is FDA-approved but has significant side effects, and antioxidants such as vitamin C, vitamin E, selenium, and N-acetylcysteine. They are to be administered before high-risk activities, for example an EVA during elevated risk. Mitigators are given after exposure to limit the progression of damage. The primary ones act on blood-cell recovery:
Acute radiation syndrome is the case where the dose record and the medical protocol meet. Diagnosis combines the time of symptom onset (nausea, vomiting), the dose estimate from the dosimeters, and a lymphocyte count if a blood test is available. Treatment follows an ordered list:
The dose thresholds in this list are expressed in Gy, so they depend on the absorbed-dose value from a dosimeter. This explains why the standard requires dose records to be reliable and quickly available to the medical officer, and why training includes simulation exercises for SPE response and ARS treatment. Counter-measures sit behind shielding and procedure in the hierarchy, and the standard does not treat them as a substitute for either.
The roadmap is staged by period. In the near term (2025-2030) it lists advanced passive shielding materials using nanotechnology, wearable real-time dosimeters, and improved SPE prediction models. The mid term (2030-2040) adds demonstrations of active electromagnetic shielding, personalised radioprotective pharmaceuticals, and in-situ resource utilization (ISRU) shielding made from lunar regolith or Martian soil. The long term (2040 onward) names compact active shielding for deep space vehicles, gene therapy for radiation resistance, and regenerative medicine for radiation damage.
Each item answers a limit identified earlier in this chapter. GCR cannot be fully shielded with practical mass, which is why active shielding and regolith-based mass are of interest. Warning times for SPEs are short, which motivates better prediction models. Individual radiosensitivity varies, which links personalised pharmaceuticals to the research priority on personalised limits. Better wearable dosimeters would also improve the data that the dose-record and threshold-alert mechanisms depend on.
Quality assurance supports this progress. Dosimeters are calibrated at least annually against NIST-traceable standards, with energy response verified across the spectrum and certificates kept. Shielding materials undergo composition verification, density measurement, and quality-control sampling. Training covers all crew with annual refreshers, and audits run before, during, and after the mission.
The chapter has followed one logic from source to response. Three environments produce different threats: GCR is chronic and hard to shield, SPE is acute and brief, and trapped radiation depends on orbit and the South Atlantic Anomaly. Those threats are measured as absorbed, equivalent, and effective dose, judged against career, short-term, and organ limits, and constrained by ALARA. Hydrogen-rich passive shielding, a storm shelter reachable in 15 minutes, and suit improvements reduce what reaches the crew. Personal and area dosimeters, with an API that raises alerts at 50%, 75%, and 90% of a limit, supply the data. The four alert levels and the EVA go/no-go conditions turn that data into decisions, and the ARS protocol covers the case where prevention fails.
The standard's compliance route is brief. A mission demonstrates conformance with a pre-mission radiation protection plan, shielding analysis, dosimetry verification, crew training records, and a medical preparedness assessment. These are reviewed by the WIA Radiation Safety Board before launch, followed by in-mission monitoring and post-mission evaluation.
The next chapter carries this approach into another area of space safety. As here, it moves from the physical hazard to explicit thresholds and from thresholds to procedures whose inputs and records can be traced and audited.